Today: January 19, 2018, 2:41 am
  
Business

Spark Therapeutics to Participate in Multiple Conferences in January

PR-Inside.com: 2018-01-02 13:34:02


PHILADELPHIA, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced that Jeffrey D. Marrazzo, chief executive officer, will present at the 36th Annual J.P. Morgan Healthcare Conference on Monday, Jan. 8, at 3:00 PM PT, at the Westin St. Francis in San Francisco.

A webcast of the presentation will be available live at the "Investors" section of www.sparktx.com. A replay of the presentation will be available on the website for 90 days following the conference.

In addition, Katherine A. High, M.D., president and head of Research & Development, will present at the following conferences:

  • New Frontiers in Coagulation Medicine on "Gene Therapy for Hemophilia: Clinical Practice & Future Perspectives" on Thursday, Jan. 11, at 12:35 PM GMT, at the De Vere Beaumont Estate in Old Windsor, England
  • Phacilitate Cell & Gene Therapy World Conference on "The Licensing of LUXTURNATM (voretigene neparvovec-rzyl)" on Tuesday, Jan. 23, at 9:15 AM ET, at the Hyatt Regency in Miami

About Spark Therapeutics
At Spark Therapeutics, a fully integrated company committed to discovering, developing and delivering gene therapies, we challenge the inevitability of genetic diseases, including blindness, hemophilia and neurodegenerative diseases. We have successfully applied our technology in the first FDA-approved gene therapy in the U.S. for a genetic disease, and currently have three programs in clinical trials, including product candidates that have shown promising early results in patients with hemophilia. At Spark, we see the path to a world where no life is limited by genetic disease. For more information, visit www.sparktx.com, and follow us on Twitter and LinkedIn.

Investor Contact:            
Ryan Asay                          
Ryan.asay@sparktx.com
(215) 239-6424                 

Media Contact:
Monique da Silva
Monique.dasilva@sparktx.com
(215) 282-7470




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Spark Therapeutics, Inc. via Globenewswire




# 519 Words
Related Articles
More From The Author
Merus to Present at the 36th Annual [..]
UTRECHT, The Netherlands, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (NASDAQ:MRUS), a clinical-stage immuno-oncology company [..]
Neste Corporation - Notification of Managers' Transactions, [..]
Neste Corporation Managers' Transactions2 January 2018 at 2 pm (EET) Neste Corporation - Notification of Managers' Transactions, [..]
How Brightline turns business strategy into business [..]
LONDON, Jan. 02, 2018 (GLOBE NEWSWIRE) -- According to Project Management Institute's 2017 survey, for every $1bn invested in [..]
Neste Corporation - Notification of Managers' Transactions, [..]
Neste Corporation Managers' Transactions 2 January 2018 at 11 am (EET) Neste Corporation - Notification of Managers' Transactions, [..]
Vela Expands Systematic Internaliser Data Hub Offering [..]
Vela, the premier market access technology provider, today announced the addition of Virtu Financial, one of the largest global [..]
 
More From Business
Discover Increases Acceptance in Hong Kong
First Data and JCB Help Discover Grow Acceptance at Key Merchants Riverwoods, Illinois, Jan 19, 2018 - (ACN Newswire) - [..]
Book Theory Test Today - Book DVSA [..]
Book Theory Test Today - Book DVSA Practical Test Looking to book a DVSA practical test? ( Whilst you may [..]
Tenant Direct - Portswood Lettings / Southampton [..]
Tenant Direct- Portswood Lettings Looking in Portswood for the latest lettings on the market? ( If so, look no further [..]
Top 5 types of cryptocurrency used in [..]
The concept of commerce has changed significantly over the last decade. Before, manufacturers had to literally fight for the [..]
Belinvestbank JSC enables acceptance of JCB Cards [..]
Minsk and Tokyo, Jan 16, 2018 - (ACN Newswire) - Belinvestbank JSC ("Belinvestbank"), a leading bank in Belarus, and [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.